Circulating soluble adhesion molecules in patients with systemic sclerosis: Correlation between circulating soluble vascular cell adhesion molecule-1 (sVCAM-1) and impaired left ventricular diastolic function

Rheumatology International

Volumn 20, Issue 1, 2000, Pages 21-24

  Shahin, A A ^a   Anwar, S ^b   Elawar, A H ^b   Sharaf, A E ^b   Hamid, M A ^b   Eleinin, A Abo ^b   Eltablawy, M ^b  

^a Cairo University ^*  (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Adhesion molecules; Diastolic dysfunction; Systemic sclerosis

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DIASTOLE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

EID: 0033639214     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002960000072     Document Type: Article

References (20)

1. Cardiopathy in systemic sclerosis
2. Heart involvement in systemic sclerosis: An ultrasonic tissue characterisation study
3. Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis
4. In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease
5. Preliminary criteria for the classification of systemic sclerosis (Scleroderma)
6. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
7. A service for the adult asthmatic
8. Doppler ultrasound in cardiology
9. Detection of increased levels of circulating intercellular adhesion molecule-1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Lack of correlation with level of circulating VCAM-1
10. Skin score: A semi-quantitative measure of cutaneous involvement which improves prediction of prognosis in systemic sclerosis (SSc)
11. Endothelial injury in scleroderma (systemic sclerosis)
12. Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity
13. Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: Enhancement by inflammatory cytokines
14. Clinical implications of soluble intercellular adhesion molecule-1 levels in systemic sclerosis
15. Increased serum levels of soluble vascular cell molecule-1 and E-selectin in patients with systemic sclerosis
16. Doppler echocardiographic assessment of left ventricular diastolic function in patients with systemic sclerosis
17. The assessment of left ventricular diastolic function in patients with systemic scleroderma by radionuclide ventriculography
18. Diastolic abnormalities in systemic sclerosis: Evidence for associated defective cardiac functional reserve
19. Endothelin-1 may be pathogenic in systemic sclerosis of the heart